Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Strategies of Genetic Study of Patients With Oculocutaneous Albinism

NCT04068961 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT04068961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04068961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
September 15, 2010
Completion date
October 31, 2010
Enrollment
64 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mutation, oculocutaneous albinism